The relationship between FDG uptake in PET scans and biological behavior in breast cancer

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

Richard L. Wahl, Robert L. Cody, Gary D. Hutchins et al. · Radiology · 1991 · 433 citations

Positron Emission Tomography, Fdg Uptake, Breast Oncology +15

The general rules for clinical and pathological recording of breast cancer

Surgery Today · 1989 · 377 citations

General Rules, Breast Oncology, Medical Imaging +13

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.

Lee P. Adler, Joseph P. Crowe, Nadia Al‐Kaisi et al. · Radiology · 1993 · 374 citations

Positron Emission Tomography, Breast Oncology, Breast Masses +15

Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.

Kotaro Higashi, Anaira C. Clavo, Richard L. Wahl · PubMed · 1993 · 313 citations

Pathology, Cell Proliferation, Measure Proliferative Activity +22

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.

Farrokh Dehdashti, Joanne Mortimer, Siegel Ba et al. · PubMed · 1995 · 291 citations